Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Do Leukocyte and Platelet Counts Have Benefit for ＼Preoperative Evaluation of Endometrial Cancer?

  • Ekici, Huseyin (Kackar State Hospital) ;
  • Malatyalioglu, Erdal (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University) ;
  • Kokcu, Arif (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University) ;
  • Kurtoglu, Emel (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University) ;
  • Tosun, Migraci (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University) ;
  • Celik, Handan (Department of Obstetrics and Gynecology, Faculty of Medicine, Ondokuz Mayis University)
  • Published : 2015.08.03
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to investigate the association between preoperative leukocyte and platelet counts and the stage of the disease in patients with endometrial cancer. Materials and Methods: Data for 100 patients undergoing total abdominal hysterectomy and bilateral salpingoophorectomy for benign uterine diseases and 177 patients surgically staged for endometrial cancer at Ondokuz Mayis University, Department of Gynecology and Obstetrics between 2005 and 2013, with preoperative complete blood count in the week prior to surgery including WBC, platelet count, pathologic evaluation for both benign and malign endometrium lesions, tumor stage and presence of lymphovascular space invasion (LVI), were retrospectively analyzed. Results: The preoperative leukocyte count was significantly higher in patients with endometrial cancer when compared to the patients with benign diseases. However, there were no significant differences in platelet counts between the groups. Patients with advanced stage endometrial cancer had higher preoperative leukocyte counts when compared to the early stage disease whereas there was no difference in platelet count. Multivariate regression analysis identified preoperative leukocytosis as an independent prognostic factor for endometrial cancer. The optimal cut-off point for WBC was calculated as 10,500 to differentiate stage 1-2-3 and 4 with 88.9% sensitivity and 86.3% specificity (AUC: 0.901, 95% CI: 0.829-0.973, p<0.001, PPV: 25.8%, NPV: 99.3%). Conclusions: Preoperative leukocytosis is independently associated with advanced endometrial cancer.

Keywords

References

  1. Acmaz G, Aksoy H, Unal D, et al (2014). Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev, 15, 1689-92. https://doi.org/10.7314/APJCP.2014.15.4.1689
  2. Amant F, Moerman P, Neven P, et al (2005). Endometrial cancer. Lancet, 366, 491-505. https://doi.org/10.1016/S0140-6736(05)67063-8
  3. Ayhan A, Bozdag G, Taskiran C, et al (2006). The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. Gynecol Oncol, 103, 902-5. https://doi.org/10.1016/j.ygyno.2006.05.034
  4. Blay JY, Negrier S, Combaret V, et al. (1992). Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res, 15, 3317-22.
  5. Brockmann MA, Giese A, Mueller K, et al (2007). Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol, 9, 335-42 https://doi.org/10.1215/15228517-2007-013
  6. Burstein SA, Harker LA. (1983). Control of platelet production. Clin Haemato, 12, 3-22.
  7. Chen YM, Whang-Peng J, Liu JM, et al. (1995). Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis. Jpn J Clin Onco, 25, 168-72.
  8. Chen CC, Yang CF, Yang MH, et al (2005). Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia. Ann Oncol, 16, 1366-73. https://doi.org/10.1093/annonc/mdi259
  9. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al (2012). GLOBOCAN Cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet]. Lyon, France: International Agency Res Cancer, 2013.
  10. Garcia-Arias A, Cetina L, Candelaria M, Robles E, Duenas Gonzalez A. (2007). The prognostic significance of leukocytosis in cervical cancer. Int J Gynecol Cancer, 17, 465-70. https://doi.org/10.1111/j.1525-1438.2007.00816.x
  11. Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O. (2009). Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer, 19, 1384-9 https://doi.org/10.1111/IGC.0b013e3181a47d47
  12. Gucer F, Moser F, Tamussino K, et al. (1998). Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol, 70, 210-4. https://doi.org/10.1006/gyno.1998.5078
  13. Hefler L, Mayerhofer K, Leibman B, et al (2000). Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol, 21, 309-14. https://doi.org/10.1159/000030136
  14. Heng S, Benjapibal M. (2014). Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev, 15, 10231-6.
  15. Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J (1992). Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer, 69, 2975-7. https://doi.org/10.1002/1097-0142(19920615)69:12<2975::AID-CNCR2820691218>3.0.CO;2-A
  16. Karpatkin S, Pearlstein E. (1981). Role of platelets in tumor cell metastases. Ann Intern Med, 95, 636-41. https://doi.org/10.7326/0003-4819-95-5-636
  17. Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ (2007). The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol, 104, 91-4. https://doi.org/10.1016/j.ygyno.2006.07.020
  18. Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ. (2007). Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol, 43, 283-8. https://doi.org/10.1016/j.oraloncology.2006.03.010
  19. Luomaranta A, Leminen A, Loukovaara M. (2013). Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol, 129, 28-32. https://doi.org/10.1016/j.ygyno.2013.01.008
  20. Mabuchi S, Matsumoto Y, Isohashi F, et al (2011). Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol, 122, 25-32. https://doi.org/10.1016/j.ygyno.2011.03.037
  21. Metindir J, Bilir Dilek G. (2009). Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol, 135, 125-9. https://doi.org/10.1007/s00432-008-0430-2
  22. Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol, 131, 410-5. https://doi.org/10.1016/j.ygyno.2013.08.032
  23. Pecorelli S (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet, 105, 103-4. https://doi.org/10.1016/j.ijgo.2009.02.012
  24. Pedersen LM, Milman N (2003). Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep, 10:213-6.
  25. Prat J (2004). Prognostic parameters of endometrial carcinoma. Hum Pathol, 35, 649-62. https://doi.org/10.1016/j.humpath.2004.02.007
  26. Sato K, Fujii Y, Ono M, Nomura H, Shizume K (1987). Production of interleukin 1 alpha-like factor and colonystimulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with hypercalcemia and leukocytosis. Cancer Res, 15, 6474-80.
  27. Scholz HS, Petru E, Gucer F, et al (2000). Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res, 20, 3983-5.
  28. Sierko E, Wojtukiewicz MZ (2004). Platelets and angiogenesis in malignancy. Semin Thromb Hemost, 30, 95-108. https://doi.org/10.1055/s-2004-822974
  29. So KA, Hong JH, Jin HM, et al (2014). The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study. Gynecol Oncol, 132, 551-5. https://doi.org/10.1016/j.ygyno.2014.01.010
  30. Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40. https://doi.org/10.1046/j.1525-1438.2001.01024.x
  31. Verheul HM, Pinedo HM. (1998). Tumor Growth: a putative role for platelets? Oncologist, 3, 2.
  32. Watanabe M, Ono K, Ozeki Y, et al. (1998). Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol, 28, 559-62. https://doi.org/10.1093/jjco/28.9.559
  33. Weiss G, Goodnough LT. (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23. https://doi.org/10.1056/NEJMra041809
  34. Worley MJ Jr, Nitschmann CC, Shoni M, et al (2012). The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol, 125, 561-5. https://doi.org/10.1016/j.ygyno.2012.03.043

Cited by

  1. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma vol.37, pp.5, 2017, https://doi.org/10.5144/0256-4947.2017.393
  2. Lower mean platelet volume predicts poor prognosis in renal cell carcinoma vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-07168-x
  3. Increased platelet distribution width predicts poor prognosis in melanoma patients vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-03212-y
  4. Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-29293-x
  5. Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-24539-0